nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—area postrema—hypertension	0.237	0.415	CbGeAlD
Lucanthone—APEX1—autonomic nervous system—hypertension	0.0548	0.0961	CbGeAlD
Lucanthone—APEX1—cardiac ventricle—hypertension	0.0174	0.0306	CbGeAlD
Lucanthone—APEX1—myocardium—hypertension	0.0164	0.0287	CbGeAlD
Lucanthone—APEX1—brainstem—hypertension	0.0132	0.0232	CbGeAlD
Lucanthone—TOP1—cardiac ventricle—hypertension	0.0122	0.0214	CbGeAlD
Lucanthone—APEX1—nephron tubule—hypertension	0.012	0.0211	CbGeAlD
Lucanthone—APEX1—adrenal cortex—hypertension	0.0118	0.0207	CbGeAlD
Lucanthone—TOP1—myocardium—hypertension	0.0115	0.0201	CbGeAlD
Lucanthone—APEX1—heart—hypertension	0.0115	0.0201	CbGeAlD
Lucanthone—APEX1—smooth muscle tissue—hypertension	0.0114	0.0199	CbGeAlD
Lucanthone—APEX1—decidua—hypertension	0.0111	0.0195	CbGeAlD
Lucanthone—APEX1—cardiovascular system—hypertension	0.0108	0.0189	CbGeAlD
Lucanthone—APEX1—kidney—hypertension	0.0106	0.0185	CbGeAlD
Lucanthone—APEX1—cortex of kidney—hypertension	0.0103	0.018	CbGeAlD
Lucanthone—APEX1—cardiac atrium—hypertension	0.0098	0.0172	CbGeAlD
Lucanthone—Cinchocaine—CALM2—hypertension	0.00975	0.439	CrCbGaD
Lucanthone—APEX1—medulla oblongata—hypertension	0.00923	0.0162	CbGeAlD
Lucanthone—APEX1—adrenal gland—hypertension	0.00855	0.015	CbGeAlD
Lucanthone—TOP1—nephron tubule—hypertension	0.00842	0.0148	CbGeAlD
Lucanthone—TOP1—adrenal cortex—hypertension	0.00829	0.0145	CbGeAlD
Lucanthone—TOP1—heart—hypertension	0.00801	0.014	CbGeAlD
Lucanthone—TOP1—smooth muscle tissue—hypertension	0.00795	0.0139	CbGeAlD
Lucanthone—TOP1—decidua—hypertension	0.0078	0.0137	CbGeAlD
Lucanthone—APEX1—endocrine gland—hypertension	0.00741	0.013	CbGeAlD
Lucanthone—TOP1—cortex of kidney—hypertension	0.00721	0.0126	CbGeAlD
Lucanthone—TOP1—cardiac atrium—hypertension	0.00685	0.012	CbGeAlD
Lucanthone—APEX1—central nervous system—hypertension	0.00668	0.0117	CbGeAlD
Lucanthone—TOP1—medulla oblongata—hypertension	0.00646	0.0113	CbGeAlD
Lucanthone—Cinchocaine—CALM1—hypertension	0.00629	0.283	CrCbGaD
Lucanthone—TOP1—adrenal gland—hypertension	0.00598	0.0105	CbGeAlD
Lucanthone—TOP2A—decidua—hypertension	0.00555	0.00972	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—PTK2—hypertension	0.00467	0.0121	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SLC9A3—hypertension	0.00466	0.0121	CbGpPWpGaD
Lucanthone—APEX1—Terbinafine—Propranolol—hypertension	0.00443	0.22	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—UTS2R—hypertension	0.00427	0.011	CbGpPWpGaD
Lucanthone—TOP2A—adrenal gland—hypertension	0.00426	0.00746	CbGeAlD
Lucanthone—APEX1—Spinal Cord Injury—MIF—hypertension	0.00425	0.011	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ADORA1—hypertension	0.00411	0.0106	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TPH1—hypertension	0.00397	0.0103	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—AQP1—hypertension	0.00386	0.00997	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ADA—hypertension	0.00378	0.00978	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ADA—hypertension	0.00378	0.00977	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—INHBA—hypertension	0.00378	0.00977	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—KDR—hypertension	0.00376	0.00972	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ROCK2—hypertension	0.0037	0.00958	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—SELP—hypertension	0.00366	0.00945	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ROCK2—hypertension	0.00358	0.00926	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—AQP4—hypertension	0.00349	0.00902	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—UTS2—hypertension	0.00337	0.00872	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—EGR1—hypertension	0.00332	0.00859	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—HDAC1—hypertension	0.00324	0.00838	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TACR1—hypertension	0.00311	0.00804	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—AHR—hypertension	0.00308	0.00798	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LGALS3—hypertension	0.00308	0.00797	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—SERPINE1—hypertension	0.00301	0.00778	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CST3—hypertension	0.00297	0.00767	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—GNAS—hypertension	0.00288	0.00744	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CST3—hypertension	0.00285	0.00736	CbGpPWpGaD
Lucanthone—TOP2A—G0 and Early G1—CCNE1—hypertension	0.00284	0.00734	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CCNE1—hypertension	0.00282	0.0073	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2—hypertension	0.00271	0.007	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL2—hypertension	0.00267	0.00691	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RPS6KB1—hypertension	0.00267	0.0069	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFBR1—hypertension	0.00266	0.00688	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—F7—hypertension	0.00256	0.00661	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ANXA1—hypertension	0.0025	0.00647	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ANXA1—hypertension	0.00249	0.00643	CbGpPWpGaD
Lucanthone—TOP2A—Salmeterol—Labetalol—hypertension	0.00242	0.12	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—SLC6A4—hypertension	0.0024	0.00621	CbGpPWpGaD
Lucanthone—Amiodarone—CYP3A5—hypertension	0.00236	0.106	CrCbGaD
Lucanthone—APEX1—Telomere Maintenance—H2AFX—hypertension	0.00234	0.00605	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—DRD3—hypertension	0.00233	0.00602	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GHRL—hypertension	0.00228	0.00589	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—hypertension	0.00225	0.00581	CbGpPWpGaD
Lucanthone—Amiodarone—ADRB1—hypertension	0.00222	0.0999	CrCbGaD
Lucanthone—APEX1—Spinal Cord Injury—NOS1—hypertension	0.00222	0.00573	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—ADIPOQ—hypertension	0.00221	0.0057	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—hypertension	0.0022	0.00568	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EP300—hypertension	0.00219	0.00565	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TH—hypertension	0.00214	0.00554	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—DRD2—hypertension	0.0021	0.00544	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—HTR7—hypertension	0.0021	0.00544	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGR1—hypertension	0.0021	0.00543	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA1—hypertension	0.0021	0.00542	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGR1—hypertension	0.00209	0.0054	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—NGFR—hypertension	0.00207	0.00536	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—VEGFA—hypertension	0.00207	0.00535	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—STK11—hypertension	0.00204	0.00528	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA1—hypertension	0.00204	0.00528	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EGR1—hypertension	0.00202	0.00522	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL10—hypertension	0.00201	0.00519	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NGFR—hypertension	0.00201	0.00519	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GJA1—hypertension	0.00199	0.00514	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AR—hypertension	0.00199	0.00513	CbGpPWpGaD
Lucanthone—TOP2A—Fluvastatin—Atorvastatin—hypertension	0.00197	0.0978	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—HDAC1—hypertension	0.00196	0.00506	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—H2AFX—hypertension	0.00195	0.00504	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—FOS—hypertension	0.00194	0.00502	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PDGFA—hypertension	0.00192	0.00495	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD6—hypertension	0.00191	0.00494	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—hypertension	0.00191	0.00494	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—NOTCH1—hypertension	0.00186	0.00481	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARGC1A—hypertension	0.0018	0.00464	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCNE1—hypertension	0.00179	0.00462	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—AVP—hypertension	0.00177	0.00458	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—H2AFX—hypertension	0.00174	0.00449	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNF—hypertension	0.00174	0.00449	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCNE1—hypertension	0.00172	0.00444	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—hypertension	0.00171	0.00442	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AHCY—hypertension	0.00169	0.00438	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3R1—hypertension	0.00169	0.00437	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PRKCA—hypertension	0.00164	0.00425	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PRKCA—hypertension	0.00163	0.00422	CbGpPWpGaD
Lucanthone—Amiodarone—CYP1A1—hypertension	0.0016	0.0721	CrCbGaD
Lucanthone—TOP1—Circadian rythm related genes—PRKCG—hypertension	0.00159	0.00411	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MTOR—hypertension	0.00156	0.00403	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Acebutolol—hypertension	0.00155	0.0767	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGFR1—hypertension	0.00148	0.00384	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SLC9A3—hypertension	0.00146	0.00377	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARA—hypertension	0.00144	0.00373	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LEP—hypertension	0.00142	0.00367	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Metoprolol—hypertension	0.0014	0.0697	CbGdCrCtD
Lucanthone—TOP1—Circadian rythm related genes—LEP—hypertension	0.00137	0.00354	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—UTS2R—hypertension	0.00133	0.00345	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ICAM1—hypertension	0.00133	0.00344	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Esmolol—hypertension	0.00133	0.066	CbGdCrCtD
Lucanthone—APEX1—Spinal Cord Injury—NOS2—hypertension	0.00132	0.00342	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Pindolol—hypertension	0.0013	0.0645	CbGdCrCtD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—hypertension	0.00129	0.00334	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ADORA1—hypertension	0.00128	0.00332	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NOS2—hypertension	0.00128	0.0033	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Penbutolol—hypertension	0.00127	0.063	CbGdCrCtD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—hypertension	0.00126	0.00327	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—SRC—hypertension	0.00125	0.00323	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TPH1—hypertension	0.00124	0.0032	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—FOS—hypertension	0.00122	0.00315	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—hypertension	0.0012	0.00309	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARG—hypertension	0.00119	0.00309	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCL2—hypertension	0.00119	0.00308	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ADA—hypertension	0.00118	0.00306	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—INHBA—hypertension	0.00118	0.00305	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—hypertension	0.00118	0.00305	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Betaxolol—hypertension	0.00117	0.0581	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—MYC—hypertension	0.00112	0.0029	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ROCK2—hypertension	0.00112	0.00289	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—hypertension	0.00108	0.0028	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SERPINE1—hypertension	0.00108	0.00278	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RHOA—hypertension	0.00107	0.00277	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—UTS2—hypertension	0.00105	0.00272	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—hypertension	0.00105	0.00271	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—hypertension	0.00103	0.00266	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hypertension	0.001	0.00259	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—hypertension	0.001	0.00259	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—hypertension	0.000978	0.00253	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—hypertension	0.000971	0.00251	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AHR—hypertension	0.000964	0.00249	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—hypertension	0.000949	0.00245	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—hypertension	0.000942	0.00244	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—hypertension	0.000939	0.00243	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—hypertension	0.000928	0.0024	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—hypertension	0.000926	0.0024	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL1B—hypertension	0.000904	0.00234	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CST3—hypertension	0.000889	0.0023	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Eplerenone—hypertension	0.000883	0.0438	CbGdCrCtD
Lucanthone—TOP2A—Chlorpromazine—Diltiazem—hypertension	0.000873	0.0433	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—hypertension	0.000855	0.00221	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—hypertension	0.000853	0.00221	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—hypertension	0.000852	0.0022	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—HDAC1—hypertension	0.000841	0.00218	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK8—hypertension	0.000835	0.00216	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFBR1—hypertension	0.000832	0.00215	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—hypertension	0.000821	0.00212	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—hypertension	0.000819	0.00212	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—hypertension	0.000814	0.0021	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—MAPK8—hypertension	0.000801	0.00207	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—F7—hypertension	0.000798	0.00206	CbGpPWpGaD
Lucanthone—TOP2A—Alprenolol—Propranolol—hypertension	0.000795	0.0394	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SRC—hypertension	0.000791	0.00205	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—hypertension	0.000782	0.00202	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—hypertension	0.000781	0.00202	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—hypertension	0.000779	0.00201	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—hypertension	0.000777	0.00201	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—hypertension	0.000771	0.00199	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Spironolactone—hypertension	0.000769	0.0381	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—SLC6A4—hypertension	0.000751	0.00194	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCNE1—hypertension	0.000737	0.00191	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—DRD3—hypertension	0.000727	0.00188	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GHRL—hypertension	0.000712	0.00184	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—hypertension	0.000709	0.00183	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—hypertension	0.000707	0.00183	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—hypertension	0.000704	0.00182	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TGFB1—hypertension	0.000702	0.00182	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—hypertension	0.000702	0.00182	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—hypertension	0.000693	0.00179	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ADIPOQ—hypertension	0.000689	0.00178	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—hypertension	0.000689	0.00178	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—hypertension	0.000681	0.00176	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TH—hypertension	0.000669	0.00173	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HDAC1—hypertension	0.000667	0.00173	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—hypertension	0.00066	0.00171	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—DRD2—hypertension	0.000658	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HTR7—hypertension	0.000658	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—hypertension	0.000657	0.0017	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—hypertension	0.000656	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—hypertension	0.000637	0.00165	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—hypertension	0.000637	0.00165	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EGR1—hypertension	0.00063	0.00163	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NGFR—hypertension	0.000627	0.00162	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AR—hypertension	0.00062	0.0016	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HDAC1—hypertension	0.000612	0.00158	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFA—hypertension	0.000598	0.00155	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HDAC1—hypertension	0.000597	0.00154	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA1—hypertension	0.000597	0.00154	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCNE1—hypertension	0.000584	0.00151	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—hypertension	0.000582	0.00151	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—hypertension	0.000578	0.00149	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARGC1A—hypertension	0.000561	0.00145	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—hypertension	0.000559	0.00145	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—hypertension	0.000558	0.00144	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AVP—hypertension	0.000553	0.00143	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—H2AFX—hypertension	0.000553	0.00143	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PRKCA—hypertension	0.000538	0.00139	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—hypertension	0.000529	0.00137	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCNE1—hypertension	0.000523	0.00135	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—hypertension	0.000516	0.00133	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PRKCA—hypertension	0.000514	0.00133	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—hypertension	0.000512	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hypertension	0.000501	0.0013	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PRKCG—hypertension	0.000497	0.00128	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—H2AFX—hypertension	0.000494	0.00128	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	0.000492	0.00127	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PRKCA—hypertension	0.000481	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—hypertension	0.000464	0.0012	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—hypertension	0.000462	0.00119	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARA—hypertension	0.000451	0.00117	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PRKCB—hypertension	0.00044	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hypertension	0.000431	0.00112	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—LEP—hypertension	0.000428	0.00111	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hypertension	0.000415	0.00107	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NOS2—hypertension	0.000399	0.00103	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PRKCB—hypertension	0.000394	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARG—hypertension	0.000373	0.000964	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—hypertension	0.000369	0.000953	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hypertension	0.000353	0.000912	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—hypertension	0.000342	0.000884	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hypertension	0.000341	0.000882	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hypertension	0.000339	0.000876	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SERPINE1—hypertension	0.000336	0.000869	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hypertension	0.000322	0.000832	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HDAC1—hypertension	0.000309	0.000798	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—hypertension	0.000306	0.000791	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—hypertension	0.000306	0.00079	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—hypertension	0.000292	0.000756	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—hypertension	0.00028	0.000723	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA1—hypertension	0.000276	0.000713	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HDAC1—hypertension	0.000276	0.000713	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCNE1—hypertension	0.00027	0.000699	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hypertension	0.000267	0.000691	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hypertension	0.000266	0.000689	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—hypertension	0.000266	0.000688	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hypertension	0.000261	0.000674	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—hypertension	0.000256	0.000661	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—H2AFX—hypertension	0.000256	0.000661	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hypertension	0.000254	0.000657	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—MAPK8—hypertension	0.00025	0.000647	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—hypertension	0.00025	0.000646	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PRKCA—hypertension	0.000249	0.000643	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hypertension	0.000247	0.000639	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—hypertension	0.000244	0.000631	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCNE1—hypertension	0.000242	0.000625	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hypertension	0.000241	0.000622	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—hypertension	0.000239	0.000617	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—hypertension	0.000238	0.000615	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—hypertension	0.000232	0.000599	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—H2AFX—hypertension	0.000229	0.000591	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PRKCA—hypertension	0.000222	0.000575	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hypertension	0.000221	0.000573	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hypertension	0.000221	0.000571	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—hypertension	0.000217	0.00056	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BIRC5—hypertension	0.000213	0.000552	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—hypertension	0.000207	0.000536	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hypertension	0.000206	0.000533	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PRKCB—hypertension	0.000204	0.000526	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PRKCB—hypertension	0.000182	0.000471	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hypertension	0.000182	0.00047	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—hypertension	0.000175	0.000451	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—hypertension	0.00017	0.00044	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—hypertension	0.00016	0.000413	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—hypertension	0.000158	0.000409	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	0.000154	0.000397	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—hypertension	0.000141	0.000366	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—hypertension	0.000129	0.000334	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—hypertension	0.000123	0.000318	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—hypertension	0.000116	0.000299	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—hypertension	0.00011	0.000284	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—hypertension	0.000107	0.000277	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—hypertension	9.59e-05	0.000248	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—hypertension	7.87e-05	0.000204	CbGpPWpGaD
